Adherence to dabigatran therapy and longitudinal patient outcomes: Insights from the Veterans Health Administration

BACKGROUND: Dabigatran is a novel oral anti-coagulant (NOAC) that reduces risk of stroke in patients with non-valvular atrial fibrillation (NVAF). It does not require routine monitoring with laboratory testing which may have an adverse impact on adherence. We aimed to describe adherence to dabigatra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am Heart J
Main Authors: Shore, Supriya, Carey, Evan P., Turakhia, Mintu P., Jackevicius, Cynthia A., Cunningham, Fran, Pilote, Louise, Bradley, Steven M., Maddox, Thomas M., Grunwald, Gary K., Barón, Anna E., Rumsfeld, John S., Varosy, Paul D., Schneider, Preston M., Marzec, Lucas N., Ho, P. Michael
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5381802/
https://ncbi.nlm.nih.gov/pubmed/24890529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2014.03.023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados